IBIO
Price:
$1.78
Market Cap:
$15.35M
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing re...[Read more]
Industry
Biotechnology
IPO Date
2008-08-19
Stock Exchange
AMEX
Ticker
IBIO
According to iBio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of -46.92% compared to the average of -0.47 of the last 4 quarters.
The mean historical PE Ratio of iBio, Inc. over the last ten years is -54.96. The current -0.25 PE Ratio has changed -54.51% with respect to the historical average. Over the past ten years (40 quarters), IBIO's PE Ratio was at its highest in in the June 2021 quarter at 14.13K. The PE Ratio was at its lowest in in the June 2020 quarter at -345.51.
Average
-54.96
Median
-12.29
Minimum
-205.04
Maximum
-0.04
Discovering the peaks and valleys of iBio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 878.71%
Maximum Annual PE Ratio = -0.04
Minimum Annual Increase = -99.65%
Minimum Annual PE Ratio = -205.04
Year | PE Ratio | Change |
---|---|---|
2023 | -0.25 | 473.23% |
2022 | -0.04 | -99.65% |
2021 | -12.70 | 72.32% |
2020 | -7.37 | 878.71% |
2019 | -0.75 | -93.66% |
2018 | -11.88 | -75.16% |
2017 | -47.83 | -59.95% |
2016 | -119.42 | -41.76% |
2015 | -205.04 | 42.11% |
2014 | -144.28 | 101.21% |
The current PE Ratio of iBio, Inc. (IBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.33
5-year avg
-4.22
10-year avg
-54.96
iBio, Inc.’s PE Ratio is less than Jaguar Health, Inc. (-0.07), greater than Onconova Therapeutics, Inc. (-1.15), greater than GeoVax Labs, Inc. (-0.32), greater than Ocugen, Inc. (-5.77), less than Tonix Pharmaceuticals Holding Corp. (-0.00), greater than Acasti Pharma Inc. (-2.21), less than Diffusion Pharmaceuticals Inc. (-0.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.55), greater than Palisade Bio, Inc. (-0.31), less than Vaxart, Inc. (0), greater than ADMA Biologics, Inc. (-2.16), less than BioCryst Pharmaceuticals, Inc. (108.63), greater than null (-11.29),
Company | PE Ratio | Market cap |
---|---|---|
-0.07 | $10.26M | |
-1.15 | $20.90M | |
-0.32 | $28.68M | |
-5.77 | $328.16M | |
-0.00 | $3.14M | |
-2.21 | $24.44M | |
-0.00 | $8.98M | |
-0.55 | $4.53M | |
-0.31 | $4.25M | |
0 | $201.33M | |
-2.16 | $3.79B | |
108.63 | $1.65B | |
-11.29 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iBio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like iBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is iBio, Inc.'s PE Ratio?
How is the PE Ratio calculated for iBio, Inc. (IBIO)?
What is the highest PE Ratio for iBio, Inc. (IBIO)?
What is the 3-year average PE Ratio for iBio, Inc. (IBIO)?
What is the 5-year average PE Ratio for iBio, Inc. (IBIO)?
How does the current PE Ratio for iBio, Inc. (IBIO) compare to its historical average?